ArticleJournal of clinical medicine2026

Efficacy, Safety, and Survival Outcomes of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient Colorectal Cancer: A Retrospective, Multicenter Study.

Mehmet Cihan İcli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.